# KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

> **NCT06566794** · NA · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 12 (actual)

## Conditions studied

- Drug Interaction

## Interventions

- **DRUG:** Caffeine Tablet
- **DRUG:** Bupropion Hydrochloride Capsels
- **DRUG:** Repaglinide Capsels
- **DRUG:** Flurbiprofen Capsels
- **DRUG:** Omeprazole 10 MG
- **DRUG:** Dextromethorphan Oral Solution
- **DRUG:** Midazolam oral solution
- **DRUG:** Simvastatin tablets
- **DRUG:** Placebo
- **DRUG:** Carvedilol
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT06566794
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-22
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-01-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566794, "KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06566794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*